Lexicon Pharma (LXRX) Tops Q2 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. TFII
6. LYB
7. LITE
8. NVT
9. SPY
10. AAPL

Go back to Lexicon Pharma (LXRX) Tops Q2 EPS by 5c

Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update

August 7, 2015 7:00 AM EDT

THE WOODLANDS, Texas, Aug. 7, 2015 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the second quarter ended June 30, 2015 and provided an overview of key milestones for the company's lead drug candidates.

Earlier this week, Lexicon announced that its most advanced drug candidate, telotristat etiprate, achieved statistically significant... More